Replies to post #115664 on Biotech Values

[pcrutch]

Seems odd that this was approved given an expert panel shot them down on meager benefits. Sometimes the FDA's decisions really make me scratch my head. Doubt this can really compete with Advair

http://www.fiercebiotech.com/story/fda-panel-rejects-forest-nycomed-drug-daxas-copd/2010-04-08